Current management of impingement syndrome and repairable rotator cuff tears in South Korea: A web-based survey Authors: Hyungsuk Kim, Jae-Hoo Lee, Ji Young Yoon, Hyojune Kim, Jae Soo Kim, Seong Hun Kim Published: 2026 ABSTRACT BackgroundDespite advances in arthroscopic techniques and accumulating clinical evidence, the management of impingement symptoms without a definite rotator cuff tear and repairable rotator cuff tears remains variable in daily practice. Understanding contemporary practice patterns may help identify areas of consensus and variation and inform future guideline development.MethodsA nationwide, cross-sectional, web-based survey was conducted among members of the Korean Arthroscopy Society. The full questionnaire consisted of 110 items; the present study analyzed 37 items addressing impingement symptoms without a definite rotator cuff tear, acromioplasty during rotator cuff repair, management of concomitant long head of the biceps pathology, indications and techniques for partial-thickness tears, repair strategies for repairable full-thickness tears, and decision-making for subscapularis tears. Responses were summarized descriptively. Majority consensus was defined as selection by at least half of respondents. Subgroup analyses were performed according to practice setting, comparing university-based and non-university-based surgeons.ResultsA total of 100 surgeons completed the survey. Most respondents reported that they rarely consider surgery for impingement symptoms without a definite rotator cuff tear and that escalation to surgery is primarily driven by persistent symptoms rather than imaging findings alone. During rotator cuff repair, acromioplasty was commonly performed, typically limited to spur excision. Management of long head of the biceps pathology showed strong consensus, with treatment decisions guided mainly by patient age and activity level and a preference for tenotomy in older patients. For partial-thickness rotator cuff tears, operative thresholds varied, particularly for lower-grade tears; however, when surgery was selected for partial articular-sided lesions, tear completion followed by repair was the most commonly preferred approach. Suture-bridge constructs were strongly favored for repairable full-thickness tears, with tear size, retraction, and tissue quality identified as the primary determinants of construct selection. Practice-setting differences were observed in the timing of escalation from conservative care and in the selective use of biologic adjuncts, including greater use of bioinductive patches for bursal-sided partial-thickness tears in university-based settings.ConclusionThis nationwide survey suggests that Korean shoulder surgeons have generally aligned their practice with contemporary evidence by avoiding routine surgery for impingement without a definite tear and by applying anatomy-driven strategies for repairable rotator cuff tears. Persistent variability in operative thresholds for partial-thickness tears and selective use of biologic adjuncts highlights areas where further evidence synthesis and consensus guidance may help reduce practice variation and support standardized, value-based care.Level of evidenceLevel IV, Cross-sectional survey study Introduction Rotator cuff disease is one of the most common causes of shoulder pain and functional limitation and represents a substantial and growing surgical burden in South Korea. National epidemiologic data have demonstrated increasing surgical trends for rotator cuff pathology in Korea, reflecting population aging and expanding utilization of arthroscopic treatment.1,2 Despite the high procedure volume, several aspects of contemporary management remain preference-sensitive, and practice patterns may vary across institutions depending on case mix, resource availability, and surgeon training. For patients presenting with impingement-type symptoms without a definite rotator cuff tear, the role of operative management such as arthroscopic subacromial decompression, acromioplasty, and/or bursectomy has been debated for decades.3, 4, 5, 6 Although acromial morphology and subacromial spurs have historically been considered relevant anatomic factors,5,6 contemporary evidence suggests that the relationship between these findings, symptoms, and outcomes is complex, and indications for surgery after failed nonoperative care remain inconsistent across surgeons and healthcare systems.3,5 Furthermore, the content and duration of initial conservative treatment vary in real-world practice, including the relative use of medication, supervised physiotherapy, injections, and extracorporeal shockwave therapy, reflecting heterogeneity in both physician preference and local resource availability.7,8 Even when rotator cuff repair is performed, substantial variation persists regarding adjunct procedures and technical strategies. The role of routine acromioplasty performed during rotator cuff repair remains controversial, and there is no clear agreement on how much bone should be resected. Clinical studies have reported conflicting results, and debate continues regarding whether acromioplasty meaningfully improves postoperative pain, tendon healing, or retear rates in repairable tears.9, 10, 11 Similarly, the management of concomitant long head of the biceps pathology is highly variable. Selection of surgical management for long head of the biceps pathology is typically guided by patient-specific factors such as age, activity level, symptoms, and clinical signs of instability, as well as the expected risk of cosmetic deformity. In addition, surgeons vary in whether they recommend operative treatment for isolated biceps pathology when a rotator cuff tear is not present.12,13 When tenodesis is performed, the choice of fixation technique further contributes to variation in practice and may reflect differences in surgeon training and institutional preference.14, 15, 16. Partial-thickness rotator cuff tears are another area in which indications for surgery and operative strategies vary widely. Many surgeons use the extent of tendon involvement as a practical threshold when deciding between debridement and repair, but there is no uniform approach to applying this concept across different tear patterns. In addition, surgeons differ in how they treat partial articular-sided tendon avulsion (PASTA) lesions, with preferences ranging from preserving the remaining intact tendon and repairing in situ to completing the tear and then performing a standard repair.17, 18, 19, 20 For repairable full-thickness tears, surgeons select the repair construct based on factors such as tear size, the degree of tendon retraction, and tissue quality, along with patient characteristics and individual surgical preference. As a result, the chosen repair strategy can vary across different practice settings.21, 22, 23, 24, 25, 26. Finally, the management of subscapularis tears has advanced with improvements in imaging and arthroscopic techniques, yet important variations remain in both indications and operative approach. Surgeons commonly rely on established classification systems, including the Lafosse system21 and the Yoo and Rhee system,27 to describe tear patterns and severity. However, there is no uniform agreement on the severity at which repair should be recommended, where the repair should be performed, or whether additional steps such as comma tissue repair and coracoplasty should be routinely included.28, 29, 30, 31. To support guideline development and to benchmark contemporary clinical practice, the Korean Arthroscopy Society (KAS) conducted a nationwide web-based survey of its members. The purpose of this study was to characterize current management patterns for subacromial pain without a definite rotator cuff tear and for repairable rotator cuff tears among shoulder surgeons in South Korea, to identify areas of majority agreement, and to explore differences by practice setting. Material & methods Study design This study was a cross-sectional, web-based survey of KAS members who manage shoulder disorders as a primary or secondary area of practice. The questionnaire was distributed through the KAS official e-mail system, and responses were submitted via an online form. All responses were collected anonymously, and the authors had no access to respondents’ names or e-mail addresses. The survey was open for six weeks (August 1 to September 15, 2025). Practice-setting information was required to complete the submission, whereas responses to the remaining items were optional. Survey contents The questionnaire was developed by a specialized survey committee within the KAS, comprising six board-certified orthopedic surgeons specializing in shoulder surgery, each with more than 10 years of clinical experience. The items were established through iterative expert reviews to ensure content validity and were pilot-tested for clarity before final distribution. The full questionnaire comprised 110 items. For the present analysis, we evaluated the “repairable rotator cuff tear” section (37 items; questions 1–36 and 111), covering (1) conservative management and thresholds for considering surgery in subacromial pain/impingement without a definite tear, (2) use and extent of acromioplasty during rotator cuff repair, (3) management of concomitant long head of the biceps pathology, (4) indications and preferred techniques for partial-thickness tears (articular- and bursal-sided), (5) repair constructs and adjunct procedures for repairable full-thickness tears including patch-related strategies, and (6) decision thresholds and technical preferences for subscapularis tears. This thematic selection was prospectively planned to ensure a focused and in-depth clinical discussion, as the remaining items addressed distinct clinical entities such as massive/irreparable tears and postoperative rehabilitation protocols. To minimize respondent burden and survey fatigue, these diverse topics were consolidated into a single comprehensive survey, with results intended for separate reporting based on clinical theme to maintain thematic consistency and avoid excessive manuscript length. Table 1 lists the survey items analyzed in this study.Table 1Survey items on the current management of impingement syndrome and repairable rotator cuff tears (questions 1–36 and 111).Table 1QuestionSurvey item (English translation)1In patients with impingement syndrome without a definite rotator cuff tear, do you consider surgical interventions such as acromioplasty or bursectomy?2If you consider surgical treatment, after how long of a trial of conservative management do you typically make that decision?3When initiating conservative treatment, which modality do you consider first? (select all that apply)4What are the main factors that lead you to consider surgical treatment? (select all that apply)5Do you perform acromioplasty when conducting rotator cuff repair?6To what extent do you typically resect during acromioplasty?7What are the main factors influencing your decision to perform acromioplasty? (select all that apply)8What are the main factors influencing your decision to treat biceps pathology? (select all that apply)9What factors do you consider when deciding between biceps tenodesis and tenotomy? (select all that apply)10If you perform tenodesis, which fixation method do you use?11In cases of isolated biceps pathology without a concomitant rotator cuff tear, do you still perform surgery?12In patients >65 years of age undergoing rotator cuff repair, which method do you prefer for managing the biceps?13In cases of partial-thickness articular-sided tears (PASTA lesions) requiring surgical treatment, which repair technique do you prefer?14For a PASTA lesion involving <50% of tendon thickness, do you consider surgical treatment?15For a PASTA lesion involving >50% of tendon thickness, do you consider surgical treatment?16What is the most important factor influencing your decision to proceed with surgery for a PASTA lesion?17When considering surgical treatment for a PASTA lesion, after how long of a trial of conservative management do you typically make the decision?18When considering surgical treatment for a bursal-sided partial-thickness rotator cuff tear (PTRCT), after how long of a trial of conservative management do you typically make the decision?19What is the most important factor influencing your decision to proceed with surgery for a bursal-sided PTRCT?20For a bursal-sided PTRCT involving <50% of tendon thickness, do you consider surgical treatment?21For a bursal-sided PTRCT involving >50% of tendon thickness, do you consider surgical treatment?22When performing surgical treatment for a bursal-sided PTRCT, which repair technique do you prefer?23In the surgical treatment of a bursal-sided PTRCT, do you perform any additional adjunct procedures? (select all that apply)24For a bursal-sided PTRCT, do you use a bioinductive patch (e.g., Regeneten®, acellular dermal matrix (ADM), collagen)?25For repairable full-thickness rotator cuff tears, which repair technique do you prefer?26What factors do you consider when selecting a repair technique for a repairable full-thickness tear? (select all that apply)27What is the most important factor in your decision to proceed with surgery for a repairable full-thickness tear?28In surgical treatment of a repairable full-thickness tear, do you perform any additional adjunct procedures? (select all that apply)29For small- to medium-sized full-thickness rotator cuff tears, do you use a bioinductive patch (e.g., Regeneten)?30For small- to medium-sized full-thickness rotator cuff tears, do you perform patch augmentation (e.g., ADM)?31What is the most important factor influencing your decision to proceed with surgery for a subscapularis tear?32aAt which stage would you consider surgical treatment for a subscapularis tear (Yoo and Rhee classification)?32bAt which stage would you consider surgical treatment for a subscapularis tear (Lafosse classification)?33For a Type IIB subscapularis tear according to the Yoo and Rhee classification, how often do you consider surgical treatment?34In subscapularis tear repair, which surgical approach do you prefer?35When performing subscapularis repair, do you also repair the comma tissue?36When performing subscapularis repair, do you perform coracoplasty?111If the results of this survey differ from your current clinical practice, would you be willing to modify your treatment protocol accordingly?Regeneten® is a bioinductive collagen implant (Smith & Nephew, Andover, MA, USA). Table 1Survey items on the current management of impingement syndrome and repairable rotator cuff tears (questions 1–36 and 111).Table 1QuestionSurvey item (English translation)1In patients with impingement syndrome without a definite rotator cuff tear, do you consider surgical interventions such as acromioplasty or bursectomy?2If you consider surgical treatment, after how long of a trial of conservative management do you typically make that decision?3When initiating conservative treatment, which modality do you consider first? (select all that apply)4What are the main factors that lead you to consider surgical treatment? (select all that apply)5Do you perform acromioplasty when conducting rotator cuff repair?6To what extent do you typically resect during acromioplasty?7What are the main factors influencing your decision to perform acromioplasty? (select all that apply)8What are the main factors influencing your decision to treat biceps pathology? (select all that apply)9What factors do you consider when deciding between biceps tenodesis and tenotomy? (select all that apply)10If you perform tenodesis, which fixation method do you use?11In cases of isolated biceps pathology without a concomitant rotator cuff tear, do you still perform surgery?12In patients >65 years of age undergoing rotator cuff repair, which method do you prefer for managing the biceps?13In cases of partial-thickness articular-sided tears (PASTA lesions) requiring surgical treatment, which repair technique do you prefer?14For a PASTA lesion involving <50% of tendon thickness, do you consider surgical treatment?15For a PASTA lesion involving >50% of tendon thickness, do you consider surgical treatment?16What is the most important factor influencing your decision to proceed with surgery for a PASTA lesion?17When considering surgical treatment for a PASTA lesion, after how long of a trial of conservative management do you typically make the decision?18When considering surgical treatment for a bursal-sided partial-thickness rotator cuff tear (PTRCT), after how long of a trial of conservative management do you typically make the decision?19What is the most important factor influencing your decision to proceed with surgery for a bursal-sided PTRCT?20For a bursal-sided PTRCT involving <50% of tendon thickness, do you consider surgical treatment?21For a bursal-sided PTRCT involving >50% of tendon thickness, do you consider surgical treatment?22When performing surgical treatment for a bursal-sided PTRCT, which repair technique do you prefer?23In the surgical treatment of a bursal-sided PTRCT, do you perform any additional adjunct procedures? (select all that apply)24For a bursal-sided PTRCT, do you use a bioinductive patch (e.g., Regeneten®, acellular dermal matrix (ADM), collagen)?25For repairable full-thickness rotator cuff tears, which repair technique do you prefer?26What factors do you consider when selecting a repair technique for a repairable full-thickness tear? (select all that apply)27What is the most important factor in your decision to proceed with surgery for a repairable full-thickness tear?28In surgical treatment of a repairable full-thickness tear, do you perform any additional adjunct procedures? (select all that apply)29For small- to medium-sized full-thickness rotator cuff tears, do you use a bioinductive patch (e.g., Regeneten)?30For small- to medium-sized full-thickness rotator cuff tears, do you perform patch augmentation (e.g., ADM)?31What is the most important factor influencing your decision to proceed with surgery for a subscapularis tear?32aAt which stage would you consider surgical treatment for a subscapularis tear (Yoo and Rhee classification)?32bAt which stage would you consider surgical treatment for a subscapularis tear (Lafosse classification)?33For a Type IIB subscapularis tear according to the Yoo and Rhee classification, how often do you consider surgical treatment?34In subscapularis tear repair, which surgical approach do you prefer?35When performing subscapularis repair, do you also repair the comma tissue?36When performing subscapularis repair, do you perform coracoplasty?111If the results of this survey differ from your current clinical practice, would you be willing to modify your treatment protocol accordingly?Regeneten® is a bioinductive collagen implant (Smith & Nephew, Andover, MA, USA). Survey items on the current management of impingement syndrome and repairable rotator cuff tears (questions 1–36 and 111). Regeneten® is a bioinductive collagen implant (Smith & Nephew, Andover, MA, USA). Statistical analysis Responses were exported to Microsoft Excel and analyzed using Python. Categorical variables are presented as counts and percentages. Because some items were optional, denominators varied across questions and are reported accordingly. For single-answer items, an option selected by ≥ 50% of respondents was considered a majority consensus response. For multiple-answer items, each option is summarized by its selection rate, and options selected by ≥ 50% were considered consensus items. Because this study was intended to describe prevailing practice patterns rather than establish a formal consensus through a Delphi process, a threshold of ≥50% was pragmatically chosen to indicate majority agreement. For exploratory subgroup comparisons, respondents practicing at university hospitals were classified as Group U, whereas those working in non-university institutions were classified as Group N. Group differences in categorical responses were assessed using the chi-square test or Fisher's exact test, as appropriate. To account for multiple testing across the 37 items, the Benjamini-Hochberg procedure was applied to the 87 individual statistical comparisons (including separate binary analyses for each option in multiple-choice questions). To assess the magnitude of observed differences, effect sizes were calculated using Cramer's V, with values of 0.1, 0.3, and 0.5 representing small, medium, and large effects, respectively. Both unadjusted and adjusted p-values were reported to provide a comprehensive view of the exploratory findings, and statistical significance was defined as an adjusted p-value <0.05. Following the overall chi-square test, adjusted standardized residuals were calculated as post hoc analyses to identify category-specific differences. A value greater than ±1.96 was considered indicative of a meaningful contribution to the overall association. Results Respondent characteristics The survey was specifically sent to 140 KAS members who identified shoulder surgery as their primary specialty, and 100 surgeons completed the survey (response rate: 71.4%). Respondents most practiced at university hospitals (40/100, 40%), followed by specialty hospitals (23/100, 23%), general hospitals (17/100, 17%), community hospitals (16/100, 16%), and clinics (4/100, 4%). Because some items were optional, denominators varied across questions and are reported accordingly. Majority consensus responses/items (≥50% selection rate) across the survey are summarized in Table 2.Table 2Survey items that reached majority consensus (≥50% agreement).Table 2Survey itemItem typeMajority consensus response/item (≥50%)n/N (%)Consider surgery for impingement without definite tear?Single choiceExtremely rarely51/100 (51.0)Initial conservative modalityMultiple-choiceMedication60/100 (60.0)Factors prompting surgeryMultiple-choicePersistent pain87/98 (88.8)Perform acromioplasty during RCR?Single choiceActively53/100 (53.0)Extent of acromioplasty resectionSingle choiceSpur excision only63/99 (63.6)Determinants for acromioplastyMultiple-choiceSpurs presence79/99 (79.8)Determinants to treat biceps pathologyMultiple-choiceAge63/100 (63.0)Determinants to treat biceps pathologyMultiple-choicePain59/100 (59.0)Determinants to treat biceps pathologyMultiple-choiceTear severity59/100 (59.0)Factors for tenodesis vs tenotomyMultiple-choiceAge90/100 (90.0)Factors for tenodesis vs tenotomyMultiple-choiceActivity level71/100 (71.0)Preferred tenodesis fixation methodSingle choiceA/S suprapectoral – suture anchor71/100 (71.0)Operate for isolated biceps pathology without rotator cuff tear?Single choiceAlmost never51/100 (51.0)Preferred biceps management in patients >65 years during RCRSingle choiceTenotomy60/100 (60.0)Preferred technique for PASTA lesions requiring surgerySingle choiceTake down and repair65/99 (65.7)Key factor prompting surgery for PASTA lesionsSingle choicePain54/99 (54.5)Conservative treatment duration before surgery for PASTA lesionsSingle choice3 months52/100 (52.0)Conservative treatment duration before surgery for bursal-sided PTRCTSingle choice3 months57/100 (57.0)Key factor prompting surgery for bursal-sided PTRCTSingle choicePain63/99 (63.6)Preferred repair technique for bursal-sided PTRCTSingle choiceSuture-bridge repair54/100 (54.0)Adjunct procedures for bursal-sided PTRCTMultiple-choiceCollagen injection77/96 (80.2)Preferred technique for repairable full-thickness tearsSingle choiceSuture-bridge repair77/100 (77.0)Factors for selecting repair techniqueMultiple-choiceTear size70/100 (70.0)Factors for selecting repair techniqueMultiple-choiceRetraction extent64/100 (64.0)Factors for selecting repair techniqueMultiple-choiceTissue quality61/100 (61.0)Adjunct procedures for repairable full-thickness tearsMultiple-choiceCollagen injection79/99 (79.8)Use bioinductive patch for small–medium full-thickness tears?Single choiceAlmost never60/100 (60.0)Use patch augmentation (e.g., ADM) for small–medium full-thickness tears?Single choiceAlmost never56/100 (56.0)Threshold for subscapularis surgery (Yoo & Rhee classification)Single choiceType IIB58/99 (58.6)Threshold for subscapularis surgery (Lafosse classification)Single choiceStage 262/99 (62.6)Perform coracoplasty during subscapularis repair?Single choiceAlmost never77/100 (77.0)Willingness to change practice if survey differs from current practiceSingle choiceWould consider changing64/99 (64.6) Table 2Survey items that reached majority consensus (≥50% agreement).Table 2Survey itemItem typeMajority consensus response/item (≥50%)n/N (%)Consider surgery for impingement without definite tear?Single choiceExtremely rarely51/100 (51.0)Initial conservative modalityMultiple-choiceMedication60/100 (60.0)Factors prompting surgeryMultiple-choicePersistent pain87/98 (88.8)Perform acromioplasty during RCR?Single choiceActively53/100 (53.0)Extent of acromioplasty resectionSingle choiceSpur excision only63/99 (63.6)Determinants for acromioplastyMultiple-choiceSpurs presence79/99 (79.8)Determinants to treat biceps pathologyMultiple-choiceAge63/100 (63.0)Determinants to treat biceps pathologyMultiple-choicePain59/100 (59.0)Determinants to treat biceps pathologyMultiple-choiceTear severity59/100 (59.0)Factors for tenodesis vs tenotomyMultiple-choiceAge90/100 (90.0)Factors for tenodesis vs tenotomyMultiple-choiceActivity level71/100 (71.0)Preferred tenodesis fixation methodSingle choiceA/S suprapectoral – suture anchor71/100 (71.0)Operate for isolated biceps pathology without rotator cuff tear?Single choiceAlmost never51/100 (51.0)Preferred biceps management in patients >65 years during RCRSingle choiceTenotomy60/100 (60.0)Preferred technique for PASTA lesions requiring surgerySingle choiceTake down and repair65/99 (65.7)Key factor prompting surgery for PASTA lesionsSingle choicePain54/99 (54.5)Conservative treatment duration before surgery for PASTA lesionsSingle choice3 months52/100 (52.0)Conservative treatment duration before surgery for bursal-sided PTRCTSingle choice3 months57/100 (57.0)Key factor prompting surgery for bursal-sided PTRCTSingle choicePain63/99 (63.6)Preferred repair technique for bursal-sided PTRCTSingle choiceSuture-bridge repair54/100 (54.0)Adjunct procedures for bursal-sided PTRCTMultiple-choiceCollagen injection77/96 (80.2)Preferred technique for repairable full-thickness tearsSingle choiceSuture-bridge repair77/100 (77.0)Factors for selecting repair techniqueMultiple-choiceTear size70/100 (70.0)Factors for selecting repair techniqueMultiple-choiceRetraction extent64/100 (64.0)Factors for selecting repair techniqueMultiple-choiceTissue quality61/100 (61.0)Adjunct procedures for repairable full-thickness tearsMultiple-choiceCollagen injection79/99 (79.8)Use bioinductive patch for small–medium full-thickness tears?Single choiceAlmost never60/100 (60.0)Use patch augmentation (e.g., ADM) for small–medium full-thickness tears?Single choiceAlmost never56/100 (56.0)Threshold for subscapularis surgery (Yoo & Rhee classification)Single choiceType IIB58/99 (58.6)Threshold for subscapularis surgery (Lafosse classification)Single choiceStage 262/99 (62.6)Perform coracoplasty during subscapularis repair?Single choiceAlmost never77/100 (77.0)Willingness to change practice if survey differs from current practiceSingle choiceWould consider changing64/99 (64.6) Survey items that reached majority consensus (≥50% agreement). Management of subacromial pain without a definite rotator cuff tear For subacromial pain/impingement syndrome without a definite rotator cuff tear (n = 100), a majority consensus response was “extremely rarely” considering surgical treatment such as acromioplasty or bursectomy (51/100, 51.0%). When surgery was considered, no majority consensus was observed regarding the duration of conservative management before decision-making; however, the most common responses were ≥3 months (37%) and ≥6 months (35%). In subgroup analysis, the distribution of “time before considering surgery” differed between university-hospital (Group U) and non-university (Group N) respondents (unadjusted p = 0.001, Cramer's V = 0.354). Group U more commonly selected ≥6 months (20/40, 50.0%) than Group N (15/60, 25.0%), whereas Group N more commonly selected ≥3 months (29/60, 48.3%) than Group U (8/40, 20.0%) (Fig. 1). Post hoc analysis indicated that the ≥3 months category was more frequent in Group N, whereas the ≥6 months category was more frequent in Group U.Fig. 1Duration of conservative treatment before considering surgery for subacromial pain without a definite rotator cuff tear, by practice setting (Group U vs Group N). Duration of conservative treatment before considering surgery for subacromial pain without a definite rotator cuff tear, by practice setting (Group U vs Group N). As initial conservative modalities (multiple responses allowed; n = 100), majority consensus items were injection therapy (75/100, 75.0%) and medication (60/100, 60.0%). Among factors prompting consideration of surgery (multiple responses allowed; n = 98), a majority consensus item was persistent pain (87/98, 88.8%). Concomitant procedures during rotator cuff repair: acromioplasty and biceps management For acromioplasty during rotator cuff repair (n = 100), a majority consensus response was “actively performed” (53/100, 53.0%). When acromioplasty was performed, a majority consensus response for resection extent was “spur excision only” (63/99, 63.6%). The most frequently selected determinant for performing acromioplasty (multiple responses allowed; n = 99) was spur presence, which met the majority consensus item criterion (79/99, 79.8%). Regarding concomitant biceps pathology, majority consensus items for deciding whether to treat the biceps (multiple responses allowed; n = 100) were age (63%), pain (59%), and tear severity (59%). For choosing between tenodesis and tenotomy (multiple responses allowed; n = 100), majority consensus items were age (90%) and activity level (71%). For tenodesis fixation (n = 100), a majority consensus response was arthroscopic suprapectoral fixation using a suture anchor (71/100, 71.0%). For isolated biceps pathology without a concomitant rotator cuff tear (n = 100), a majority consensus response was “almost never” performing surgery (51/100, 51.0%). In patients older than 65 years undergoing rotator cuff repair (n = 100), a majority consensus response was tenotomy (60/100, 60.0%). Management of partial- and full-thickness rotator cuff tears and subscapularis tears For PASTA lesions requiring operative treatment (n = 99), a majority consensus response was take-down and repair (65/99, 65.7%). For articular-sided partial-thickness tears involving <50% thickness (n = 100), no majority consensus was observed regarding whether to consider surgery; however, subgroup distributions differed between university-hospital and non-university respondents (unadjusted p = 0.012, Cramer's V = 0.263). Group U more frequently selected “extremely rarely” (22/40, 55.0%) than Group N (22/60, 36.7%), while Group N more frequently selected “case-by-case” (26/60, 43.3%) than Group U (6/40, 15.0%). For the main factor driving surgical decision-making for PASTA lesions (n = 99), a majority consensus response was pain (54/99, 54.5%). For the duration of conservative treatment before considering surgery for PASTA lesions (n = 100), a majority consensus response was 3 months (52/100, 52.0%), with subgroup differences observed between practice settings (unadjusted p = 0.004, Cramer's V = 0.319). Group U more commonly selected ≥6 months (22/40, 55.0%) than Group N (15/60, 25.0%), whereas Group N more commonly selected 3 months (35/60, 58.3%) than Group U (17/40, 42.5%). For bursal-sided partial-thickness tears, a majority consensus response for preferred repair technique was suture-bridge repair (54/100, 54.0%). For adjunct procedures during operative treatment of bursal-sided partial tears (multiple responses allowed; n = 96), a majority consensus item was collagen injection (77/96, 80.2%). Subgroup analysis showed a difference in selection rates for bioinductive patch use as an adjunct. Group U selected bioinductive patch use more frequently than Group N (18/39, 46.2% vs 14/57, 24.6%, p = 0.046) (Fig. 2).Fig. 2Selection rate of a bioinductive patch as an adjunct procedure for bursal-sided partial-thickness rotator cuff tears, overall and by practice setting (Group U vs Group N). Selection rate of a bioinductive patch as an adjunct procedure for bursal-sided partial-thickness rotator cuff tears, overall and by practice setting (Group U vs Group N). For repairable full-thickness tears (n = 100), a majority consensus response was suture-bridge repair (77/100, 77.0%). When selecting a repair technique (multiple responses allowed; n = 100), majority consensus items were tear size (70%), retraction extent (64%), and tissue quality (61%). For adjunct procedures during operative treatment of full-thickness tears (multiple responses allowed; n = 99), a majority consensus item was collagen injection (78/99, 78.8%). For small-to-medium full-thickness tears, a majority consensus response was “almost never” using a bioinductive patch (60/100, 60.0%) and “almost never” performing patch augmentation (56/100, 56.0%); the distribution for patch augmentation differed between practice settings in subgroup analysis (unadjusted p = 0.031, Cramer's V = 0.223). Group U more commonly selected “case-by-case” (19/40, 47.5%) than Group N (16/60, 26.7%), whereas Group N more commonly selected “almost never” (40/60, 66.7%) than Group U (16/40, 40.0%) (Fig. 3).Fig. 3Frequency of patch augmentation (e.g., acellular dermal matrix) for small-to-medium full-thickness rotator cuff tears, overall and by practice setting (Group U vs Group N). Frequency of patch augmentation (e.g., acellular dermal matrix) for small-to-medium full-thickness rotator cuff tears, overall and by practice setting (Group U vs Group N). For subscapularis tears, no majority consensus was observed regarding the single most important determinant for repair (n = 100). However, the most common thresholds for considering surgery met the majority consensus response definition: Type IIB in the Yoo and Rhee classification (58/99, 58.6%) and Stage 2 in the Lafosse classification (62/99, 62.6%). For coracoplasty, a majority consensus response was “almost never performed” (77/100, 77.0%). Willingness to change practice When asked whether they would change their practice if the survey results differed from their current practice (n = 99), a majority consensus response was “would consider changing” (64/99, 64.6%), followed by “very willing” (26/99, 26.3%) and “not willing” (9/99, 9.1%). Discussion This nationwide web-based survey of KAS members showed that Korean shoulder surgeons rarely consider surgery for impingement symptoms without a definite rotator cuff tear, while demonstrating majority consensus in several aspects of repairable rotator cuff tear management. In particular, surgeons commonly performed limited acromioplasty during rotator cuff repair, favored age- and activity-guided biceps treatment, and preferred suture-bridge constructs for repairable full-thickness tears. Practice-setting differences were mainly observed in thresholds for escalation from conservative care and in selected adjunct preferences. The finding that surgery is rarely considered for impingement symptoms without a definite rotator cuff tear is consistent with high-level evidence from placebo-controlled trials that failed to demonstrate a clinically meaningful advantage of routine subacromial decompression over nonoperative treatment.3,5 These studies challenged long-standing assumptions regarding mechanical impingement as the primary pain generator and emphasized the multifactorial nature of subacromial pain. The present survey suggests that these concepts have translated into real-world clinical practice in Korea, with escalation decisions largely driven by persistent symptoms rather than imaging findings alone. Variation in the duration of conservative management prior to reconsidering surgery, particularly between university and non-university institutions, likely reflects differences in access to structured nonoperative care, patient expectations, and institutional treatment pathways rather than fundamental disagreement regarding treatment principles.32,33 Despite skepticism toward decompression for isolated impingement, acromioplasty remains commonly performed during rotator cuff repair. This pattern mirrors the ongoing debate in the literature. Randomized trials and meta-analyses have reported similar clinical outcomes with and without acromioplasty in repairable rotator cuff tears,9, 10, 11,34 yet anatomical studies linking acromial morphology and lateral extension to cuff pathology continue to influence surgical thinking.35,36 The preference for limited, spur-focused resection observed in this survey suggests that many surgeons attempt to reconcile these conflicting data by applying acromioplasty selectively rather than routinely. Interestingly, 53.0% of Korean surgeons reported actively performing acromioplasty during rotator cuff repair, which is relatively higher than the 36.1% reported among members of the American Shoulder and Elbow Surgeons (ASES) in a 2015 survey.37 While international guidelines and recent trials emphasize the lack of clinical benefit for routine decompression, the preference for limited spur excision in this study suggests that Korean surgeons still value mechanical clearance in selected cases to protect the repaired tendon. This approach reflects an interpretation that focal mechanical factors may still be relevant in selected cases, even if routine decompression is not universally beneficial. Management of long head of the biceps pathology demonstrated relatively strong consensus and aligns well with prior clinical evidence. The emphasis on patient age and activity level when selecting between tenotomy and tenodesis is consistent with randomized and comparative studies showing that both procedures can reliably improve pain and function, while differences in cosmetic outcomes and patient expectations often guide selection.12,13 The concentration of practice around a limited number of tenodesis fixation strategies is also in line with data indicating that complication profiles vary by fixation location and method, encouraging surgeons to favor techniques perceived as reproducible and lower risk.14,38 Regarding biceps management, Korean surgeons showed a strong preference for tenotomy in patients older than 65 years (60.0%), identifying age as the primary determinant (90.0%). This practice pattern is closely associated with the historical reimbursement structure of the South Korean National Health Insurance (NHI) system, which until recently did not provide coverage for biceps tenodesis in patients aged 65 or older. While these insurance restrictions have been partially mitigated, the established habit of opting for tenotomy in the elderly remains prevalent, likely because it avoids potential reimbursement disputes and minimizes operative time in a population where cosmetic deformity is often perceived as a secondary concern. This contrasts with trends in the United States, where members of the ASES have shown an increasing preference for tenodesis regardless of age, driven by higher patient demands for cosmetic preservation.39 Consequently, our findings suggest that the clinical decision-making of Korean surgeons is a product of both surgical pragmatism and long-standing domestic healthcare policies. Partial-thickness rotator cuff tears remain an area of greater heterogeneity, particularly with respect to operative thresholds.40,41 Once surgery is selected for PASTA lesions, many surgeons prefer tear completion followed by repair, which is consistent with literature supporting reliable footprint restoration using this approach.17,20 However, the absence of consensus for lower-grade partial tears mirrors the longstanding debate regarding debridement-based strategies versus repair and the difficulty of defining clear thresholds for intervention.19,42 This uncertainty is well documented in prior studies and reflects the complex interplay between structural findings, symptom severity, functional demands, and patient expectations. The observed institutional differences in timing of escalation from conservative care further emphasize that decision-making in partial-thickness tears is strongly context dependent. For PASTA lesions, 65.7% of respondents preferred the take-down and repair technique, reflecting a focus on anatomical footprint restoration. This alignment with "tear completion" is consistent with the recent SECEC Delphi consensus, which acknowledges the ongoing debate between in situ and take-down repairs but notes a trend toward completion for high-grade partial tears to ensure robust mechanical fixation.43 For bursal-sided partial-thickness tears and repairable full-thickness tears, the strong preference for suture-bridge constructs aligns with biomechanical and clinical literature supporting transosseous-equivalent concepts and footprint restoration.22,23,44,45 The emphasis on tear size, retraction, and tissue quality as drivers of construct selection is consistent with established prognostic frameworks and imaging-based assessments of muscle quality and fatty degeneration.46, 47, 48 These findings indicate that, in Korea, repair strategy selection is largely anatomy- and tissue-driven rather than purely surgeon-dependent, which may facilitate future standardization efforts. With respect to biologic augmentation, the present survey revealed selective rather than routine use of bioinductive patches such as collagen-based implants. In particular, bioinductive patch use for bursal-sided partial-thickness tears was more frequently reported by surgeons in university-based settings compared with those in non-university institutions, whereas the majority of respondents reported that they almost never use bioinductive patches or formal patch augmentation for small to medium repairable full-thickness tears. This pattern is noteworthy because bioinductive patches, including resorbable collagen implants such as Regeneten (Smith & Nephew, Andover, MA, USA), have been proposed to promote tendon healing by inducing new tissue formation, particularly in partial-thickness tears with preserved native tendon continuity.49, 50, 51, 52, 53 The observed institutional difference likely reflects variations in access, cost considerations, and exposure to emerging technologies, as well as differing thresholds for adopting newer implants in routine clinical practice. This selective adoption of bioinductive patches in Korea contrasts with the latest 2025 American Academy of Orthopaedic Surgeons (AAOS) Clinical Practice Guidelines, which issued a "Strong Recommendation" for bioinductive implants in specific tear patterns based on emerging global evidence.54 The discrepancy suggests that while global trends shift toward patch-based augmentation, Korean practice remains more influenced by institutional feasibility and reimbursement considerations. At the same time, the survey demonstrated frequent use of collagen injection as an adjunct in both partial-thickness tears and small to medium repairable full-thickness tears. This preference suggests that many surgeons favor less invasive biologic strategies that can be applied without altering repair constructs or substantially increasing surgical complexity. While clinical evidence supporting injectable collagen formulations is often described as limited or heterogeneous in a global context, its frequent use in Korea is notably supported by a robust and growing body of evidence from domestic investigators.55, 56, 57 These recent Korean studies have demonstrated that intraoperative injections of collagen can enhance radiographic tendon integrity and improve clinical outcomes, including postoperative pain reduction. This suggests that the preference for injectable formulations among Korean surgeons is grounded in both locally generated clinical data and the pursuit of surgical efficiency. The widespread use of collagen injection observed in this survey highlights a pragmatic approach in which surgeons selectively integrate biologic adjuncts perceived as low risk and relatively accessible, while reserving more resource-intensive patch-based augmentation for carefully selected scenarios. Overall, the differential adoption of bioinductive patches and injectable collagen across tear types and practice settings underscores the cautious and selective integration of biologic technologies in contemporary rotator cuff surgery in Korea. These findings suggest that future consensus efforts should distinguish between partial-thickness and full-thickness pathology when discussing biologic augmentation and should consider institutional feasibility and cost-effectiveness alongside emerging clinical evidence. At the same time, the survey demonstrated frequent use of collagen injection as an adjunct in both partial-thickness tears and small to medium repairable full-thickness tears. This preference suggests that many surgeons favor less invasive biologic strategies that can be applied without altering repair constructs or substantially increasing surgical complexity. Although clinical evidence supporting injectable collagen formulations remains limited and heterogeneous, experimental and early clinical studies have suggested potential benefits in modulating the tendon healing environment and reducing postoperative pain.55, 56, 57, 58 The widespread use of collagen injection observed in this survey highlights a pragmatic approach in which surgeons selectively integrate biologic adjuncts perceived as low risk and relatively accessible, while reserving more resource-intensive patch-based augmentation for carefully selected scenarios. Overall, the differential adoption of bioinductive patches and injectable collagen across tear types and practice settings underscores the cautious and selective integration of biologic technologies in contemporary rotator cuff surgery in Korea. These findings suggest that future consensus efforts should distinguish between partial-thickness and full-thickness pathology when discussing biologic augmentation and should consider institutional feasibility and cost-effectiveness alongside emerging clinical evidence. At the same time, the survey demonstrated frequent use of collagen injection as an adjunct in both partial-thickness tears and small to medium repairable full-thickness tears. This preference suggests that many surgeons favor less invasive biologic strategies that can be applied without altering repair constructs or substantially increasing surgical complexity. Although clinical evidence supporting injectable collagen formulations remains limited and heterogeneous, experimental and early clinical studies have suggested potential benefits in modulating the tendon healing environment and reducing postoperative pain.55, 56, 57 The widespread use of collagen injection observed in this survey highlights a pragmatic approach in which surgeons selectively integrate biologic adjuncts perceived as low risk and relatively accessible, while reserving more resource-intensive patch-based augmentation for carefully selected scenarios. Overall, the differential adoption of bioinductive patches and injectable collagen across tear types and practice settings underscores the cautious and selective integration of biologic technologies in contemporary rotator cuff surgery in Korea. These findings suggest that future consensus efforts should distinguish between partial-thickness and full-thickness pathology when discussing biologic augmentation and should consider institutional feasibility and cost-effectiveness alongside emerging clinical evidence. Management of subscapularis tears remains an evolving domain with incomplete consensus. While classification systems are widely used to describe tear severity, thresholds for repair and associated technical steps vary. The tendency to consider operative treatment at moderate severity stages and to avoid routine coracoplasty is consistent with available clinical literature emphasizing careful tear characterization and selective adjunct use.21,27,28,30,59 These findings suggest gradual convergence toward more conservative and anatomy-guided strategies, while acknowledging that subscapularis decision-making remains multifactorial. Taken together, this survey demonstrates that Korean shoulder surgeons have largely aligned their practice with contemporary evidence questioning routine surgery for impingement without a definite tear, while adopting selective, anatomy-driven strategies for repairable rotator cuff pathology. Areas of persistent variation, particularly in partial-thickness tear thresholds and adjunct use, highlight where further evidence synthesis and consensus guidance may be most valuable. By distinguishing domains of convergence from those of uncertainty, the present findings provide a practical foundation for future guideline development tailored to real-world clinical practice. In particular, treatment thresholds for partial-thickness tears and the use of biologic adjuncts represent areas where greater standardization may improve consistency of care. These findings may also inform future guideline development and help align residency and fellowship training with contemporary practice patterns. Future studies incorporating prospective audit data or formal Delphi-based consensus processes may further validate these findings and help reduce unwarranted variation in clinical practice. Although the question regarding readiness to change clinical practice was presented at the end of the larger comprehensive survey, the high rate of positive responses (90.9%) indicates a strong willingness among Korean surgeons to adopt consensus-driven findings. This receptivity suggests that the insights provided in this study regarding standard repairable pathologies are likely to be actively integrated into clinical practice, further supporting the value of developing national practice guidelines. Beyond specific surgical techniques, our findings reveal significant institutional disparities that underscore the structural characteristics of the South Korean healthcare system. The longer duration of conservative management reported by university-hospital surgeons can be attributed to distinct referral patterns. Tertiary hospitals primarily treat patients who have already failed long-term conservative care in primary or secondary clinics, leading to a higher cumulative duration before surgery is considered. Furthermore, institutional variations in biologic adoption highlight the influence of resource availability and reimbursement structures. The significantly higher utilization of bioinductive patches in university settings reflects greater access to emerging technologies and a patient population with higher expectations for advanced care. Because these patches are currently high-cost and non-reimbursable, they are more readily adopted in academic centers where patients may be more willing to accept such expenses for potential biological advantages. In contrast, non-university surgeons appear to prioritize surgical efficiency and cost-effectiveness, favoring intraoperative collagen injections that are technically accessible and relatively affordable. These findings suggest that clinical practice in Korea is a pragmatic synthesis of evidence-based medicine and the economic realities of a tiered healthcare system. Limitation This study has several limitations that should be considered when interpreting the results. First, the survey-based design relies on self-reported practice patterns and preferences, which may be subject to recall bias and may not fully reflect actual day-to-day clinical decision-making. As with all questionnaire-based studies, responses may represent intended or perceived practice rather than objectively measured behavior. Second, although 100 members of the KAS participated in the survey, the sample may not be fully representative of all surgeons managing rotator cuff disease in South Korea. Participation was voluntary, and selection bias is possible, as surgeons with a particular interest in rotator cuff pathology or academic activity may have been more likely to respond. While the survey achieved a high response rate of 71.4% among 140 invited shoulder specialists, the results may still be subject to selection bias, as those with a particular interest in academic activity might have been more likely to respond. Third, some survey items were optional, resulting in varying denominators across questions. Although this reflects real-world variability in clinical experience and interest, it may limit direct comparison across all items and should be considered when interpreting specific results. Fourth, this cross-sectional survey captures practice patterns at a single time point. Surgical techniques, implant availability, rehabilitation resources, and supporting clinical evidence continue to evolve, and the observed trends may change over time. Longitudinal surveys would be required to assess temporal shifts in practice and adoption of emerging strategies. Finally, this study did not assess clinical outcomes. Accordingly, no conclusions can be drawn regarding the comparative effectiveness, safety, or cost-effectiveness of the reported management strategies. In addition, subgroup analyses based on practice setting may have been underpowered to detect more subtle differences, and the findings should therefore be interpreted with caution. Future studies incorporating additional stratification variables, such as surgeon experience or surgical volume, may provide more detailed insights into practice variation. The findings should therefore be interpreted as descriptive of current practice patterns rather than prescriptive recommendations for optimal treatment. Conclusion This nationwide survey of KAS members suggests that contemporary management of impingement symptoms and repairable rotator cuff tears in South Korea has generally aligned with current evidence, particularly in avoiding routine surgery for impingement without a definite tear and adopting anatomy-driven strategies for repairable rotator cuff pathology. While majority consensus was observed in several key areas, including repair construct selection and biceps management, meaningful variation persists in operative thresholds for partial-thickness tears and in the selective use of biologic adjuncts across practice settings. These findings provide a practical overview of current clinical trends and highlight specific areas where further evidence synthesis and consensus guidance may help reduce variability and support standardized, value-based care. Fund of this study No financial support was received for this study. Ethical review committee statement This study was conducted as a professional consensus and practice-pattern survey of orthopedic surgeons and did not involve patient data, human biological materials, or identifiable personal information. According to institutional and national regulations, ethical approval and informed consent were not required for this type of survey-based study. All responses were collected anonymously and analyzed in aggregate. Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.